Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.

Strive (ASST) has drawn attention after recent trading left the stock down about 12% over the past month and about 22% over the past 3 months, prompting investors to reassess its fundamentals.

See our latest analysis for Strive.

Even after a 5.35% 1 day share price gain to about $13.00, Strive is still carrying a weaker recent trend. Its 30 day share price return is about 12% lower, and its 1 year total shareholder return has fallen about 85%, which may raise ongoing questions about its risk profile and outlook.

If you are reassessing your options after Strive's recent volatility, it could be a good time to broaden your search and check out 18 top founder-led companies

After Strive's sharp reset and current price near $13.00, analysts see a wide gap to a consensus target around $28.80. Where might fair value sit within that spread, and what do the assumptions behind it look like?

Preferred Price-to-Book of 1.5x: Is it justified?

With Strive last closing at about $13.00 and trading on a P/B of 1.5x, the stock is being valued below both its industry and peer averages.

The price to book ratio compares the market value of Strive to its accounting book value. This can be a useful anchor for asset heavy or early stage businesses where earnings are still volatile or negative. For a company that is currently loss making, investors often pay closer attention to balance sheet strength and what each dollar of equity is being priced at.

In this case, Strive's P/B of 1.5x sits below the US Medical Equipment industry average of 2.3x and also below the peer average of 2.9x. This indicates the market is pricing the stock more cautiously than its sector and closest comparables. That discount could reflect its recent share price performance, current losses and new management and board profile. It also means any improvement in profitability or balance sheet perception would not be starting from an already stretched valuation.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-book of 1.5x (ABOUT RIGHT)

However, Strive still carries clear risks, including ongoing losses of about $700.5 million compared with revenue of $7.071 million and a 1-year total return that has fallen about 85%.

Find out about the key risks to this Strive narrative.

Next Steps

Given this mix of concern and cautious optimism around Strive, it makes sense to review the numbers yourself and decide where you stand. To see both the potential rewards and the key issues investors are watching, take a closer look at the 2 key rewards and 1 important warning sign .